Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use of HD IL-2

Wong, M. K., Morse, M. A., McDermott, D. F., Clark, J. I., Kaufman, H. L., Daniels, G. A., … Aung, S. (2015). Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use of HD IL-2. Journal for ImmunoTherapy of Cancer, 3(Suppl 2), P359. https://doi.org/10.1186/2051-1426-3-s2-p359